Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8‐Year Study at a Comprehensive Cancer Center in Jordan
Cancer Reports · 2025
DOI: 10.1002/cnr2.70132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Dana Hassouneh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan. Hauptthemen laut MEDLINE: Neoplasms, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Bacterial Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Infections impact morbidity and mortality in pediatric cancer patients, yet limited studies have assessed the microbiological profiles and susceptibility patterns of pathogenic bacteria in this population. This study aimed to investigate bacterial profiles and temporal resistance changes in pediatrics with cancer.
Methods
We identified positive cultures between January 2015 and December 2022 for pediatric patients diagnosed with cancer at age < 18 years. Electronic records provided patient demographics, microbiological profiles and resistance patterns. Using “R” programming, the dataset was refined, selecting patients' first isolate within a 30‐day period, and categorizing strains based on multidrug‐resistant (MDR) and extensively drug‐resistant (XDR) predefined criteria. Additionally, we analyzed changes in resistance patterns over the study period.
Results
Out of 1215 patients, 2992 bacterial isolates were reported, with 66% being Gram‐negative bacteria. Urine was the most common site of infection, representing 48% of cases. Among these, 42% were MDR and 2% XDR. MDR prevalence was 45% for Escherichia coli , 21% for Klebsiella pneumonia , and 14% for Staphylococcus aureus . Acinetobacter baumannii and Pseudomonas aeruginosa displayed XDR at 79% and 21%, respectively. Methicillin‐resistant S. aureus decreased from 71% in 2015 to 54% in 2022. MDR Klebsiella pneumonia peaked in 2021. MDR Pseudomonas aeruginosa decreased from 44% in 2015 to 16% in 2022.
Conclusion
Drug resistance was detected in 50% of the isolates with most being Gram‐negative and MDR. Further research is needed to identify risk factors for resistance, aiming to refine empiric antimicrobial therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.
- Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan.
- Patient Journey and Health Information Management, King Hussein Cancer Center, Amman, Jordan.
- Faculty of Medicine, University of Jordan, Amman, Jordan.
- Artificial Intelligence and Data Innovation Office, King Hussein Cancer Center, Amman, Jordan.
ORCID-Profile: Dana Hassouneh
Zitieren
APA
Hassouneh, D., Zatarah, R., AbuSara, A., Nazer, L., Abu Ghosh, A., Aryan, H. A., & Sultan, I. (2025). Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8‐Year Study at a Comprehensive Cancer Center in Jordan. Cancer Reports. https://doi.org/10.1002/cnr2.70132
Vancouver
Hassouneh D, Zatarah R, AbuSara A, Nazer L, Abu Ghosh A, Aryan HA, et al. Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8‐Year Study at a Comprehensive Cancer Center in Jordan. Cancer Reports. 2025. doi:10.1002/cnr2.70132
BibTeX
@article{Hassouneh2025,
author = {Hassouneh, Dana and Zatarah, Razan and AbuSara, Aseel and Nazer, Lama and Abu Ghosh, Amal and Aryan, Haitham Al and Sultan, Iyad},
title = {Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8‐Year Study at a Comprehensive Cancer Center in Jordan},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70132}
}
EUVIMED